Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqiaosan granules is a traditional Chinese medicine (TCM) formulation prepared in granule form, derived from the classic TCM formula Yinqiaosan (Yin Qiao San or Yinqiao powder). Originally documented in the Qing Dynasty medical text Detailed Analysis of Epidemic Warm Diseases by Wu Jutong, the formula is composed of nine primary herbs: Flos Lonicerae Japonicae (Jinyinhua), Fructus Forsythiae (Lianqiao), Herba Menthae (Bohe), Herba Schizonepetae (Jingjie), Fructus Arctii (Niubangzhi), Radix Platycodonis (Jiegeng), Semen Sojae Preparatum (Dandouchi), Radix Glycyrrhizae (Gancao), and Herba Lophatheri (Danzhuye). Yinqiaosan granules are widely used to treat wind-heat exterior syndromes, including the common cold, influenza, fever, sore throat, and acute tonsillitis. The formulation exhibits anti-inflammatory, antipyretic, antiviral, and antibacterial properties. It is being evaluated in clinical trials, such as those sponsored by the Affiliated Hospital of Changchun University of Traditional Chinese Medicine, to assess its efficacy in reducing antibiotic use and improving clinical outcomes in pediatric patients with acute tonsillitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinqiaosan granules.